Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Dec 1, 2025	307	CERTIFICATE OF SERVICE by Amgen Inc. for Amgen's Objections and Responses to Regeneron's First Set of Interrogatories (Nos. 1-3). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 12/01/2025) (2)
Nov 24, 2025	306	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Priority Requests for the Production of Documents and Things by Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/24/2025) (1)
Nov 21, 2025	302	CERTIFICATE OF SERVICE by Amgen Inc., Amgen, Inc. Amgen's Objections and Responses to Regeneron's Fourth Requests for Production of Documents to Amgen (Nos. 28-125). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2)
Nov 21, 2025	303	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's First Set of Requests for Production (Nos. 1-24). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2)
Nov 21, 2025	304	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's Second Set of Requests for Production (Nos. 25-26). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2)
Nov 21, 2025	305	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Amgen's Supplemental Responses and Objections to Regeneron's Third Set of Requests for Production (No. 27). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 11/21/2025) (2)
Nov 17, 2025	300	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron Pharmaceuticals, Inc.'s Objections and Responses to Defendant Amgen Inc.'s First Set of Interrogatories (Nos. 1-7). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/17/2025) (1)
Nov 17, 2025	301	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron Pharmaceuticals, Inc.'s Objections and Responses to Amgen Inc.'s Second Set of Requests for the Production of Documents and Things (Nos. 42 - 310). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 11/17/2025) (1)
Oct 29, 2025	299	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's First Set of Interrogatories to Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 10/29/2025) (1)
Oct 21, 2025	298	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Fourth Requests for Production of Documents to Amgen. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(Pogue, David) (Entered: 10/21/2025) (1)
Oct 15, 2025	296	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen Inc., Amgen, Inc. Amgen, Inc.'s First Set of Interrogatories to Regeneron Pharmaceuticals, Inc. (Nos. 1-7). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK(McKitrick, Kaitlyn) (Entered: 10/15/2025) (2)
Oct 15, 2025	297	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen Inc., Amgen, Inc. Defendant Amgen, Inc.'s Second Set of Requests for Production of Documents and Things to Regeneron Pharmaceuticals, Inc. (Nos. 42-310). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 10/15/2025) (2)
Sep 29, 2025	294	SCHEDULING ORDER: Discovery due by 11/4/2026. Markman Hearing set for 11/23/2026 09:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh. Motions due by 2/17/2027. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM et al.(snc) (Entered: 09/29/2025) (2)
Sep 29, 2025	295	ORDER DENYING CERTAIN MOTIONS AS MOOT (ECF NOS. 334 , 478 , 490 ). Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/29/2025) (1)
Sep 3, 2025	292	ORDER granting 616 Motion for Leave to Appear Pro Hac Vice (Jesse M. WEiss) in case 1:24-md-03103-TSK-JPM; granting (288) Motion for Leave to Appear Pro Hac Vice in case 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/03/2025) (1)
Sep 3, 2025	293	ORDER granting 617 Motion for Leave to Appear Pro Hac Vice (Timothy G. Cameron) in case 1:24-md-03103-TSK-JPM; granting (289) Motion for Leave to Appear Pro Hac Vice in case 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/03/2025) (1)
Aug 28, 2025	291	ORDER DENYING CERTAIN MOTIONS AS MOOT (ECF NOS. 181 , 299 ). Signed by Chief District Judge Thomas S. Kleeh on 08/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/28/2025) (1)
Aug 27, 2025	288	MOTION for Leave to Appear Pro Hac Vice by Jesse M. Weiss by Amgen, Inc., Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/27/2025) (0)
Aug 27, 2025	289	MOTION for Leave to Appear Pro Hac Vice by Timothy G. Cameron by Amgen Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/27/2025) (0)
Aug 27, 2025	290	Pro Hac Vice Filing fee: $ 400.00, receipt number 100004061 (for J. Weiss and T. Cameron) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/27/2025) (0)
Apr 21, 2025	287	MANDATE of USCA FOR THE FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (dk) (Entered: 04/21/2025) (1)
Mar 14, 2025	285	OPINION of USCA for the Federal Circuit as to ( 344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. USCA Decision: AFFIRMED (snc) (Entered: 03/14/2025) (20)
Mar 14, 2025	286	USCA for the Federal Circuit JUDGMENT as to ( 344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 03/14/2025) (1)
Mar 7, 2025	283	MANDATE of USCA for the Federal Circuit as to (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD., (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) (Entered: 03/07/2025) (1)
Mar 7, 2025	284	MANDATE of USCA for the Federal Circuit as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 03/07/2025) (1)
Mar 6, 2025	282	ORDER. The 164 motion is DENIED WITHOUT PREJUDICE. Associated cases: (796) in case 1:22-cv-00061-TSK-JPM; (186) in case 1:23-cv-00089-TSK-JPM; (239) in case 1:23-cv-00094-TSK-JPM; (236) in case 1:23-cv-00097-TSK-JPM; (221) in case 1:23-cv-00106-TSK-JPM; (164) in case 1:24-md-03103-TSK-JPM; (184) in case 1:24-cv-00039-TSK-JPM; (17) in case 1:24-cv-00053-TSK; in case 1:24-cv-00085-TSK. Signed by Chief District Judge Thomas S Kleeh on 3/6/2025. (dk) (Entered: 03/06/2025) (1)
Mar 5, 2025	280	OPINION OF USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA Decision: AFFIRMED (dk) (Entered: 03/05/2025) (10)
Mar 5, 2025	281	JUDGMENT OF THE USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (dk) (Entered: 03/05/2025) (1)
Jan 29, 2025	278	OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025) (30)
Jan 29, 2025	279	USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025) (1)
Dec 12, 2024	276	MOTION to Withdraw as Attorney ANISH R. DESAI, KATHRYN LEICHT, KELLIE VAN BECK, MATTHEW D. SEIGER, NATALIE C. KENNEDY, TOM YU, AND ZHEN LIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/12/2024) (4)
Dec 12, 2024	277	ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. 426 , 427 , 438 . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. 429 , 431 . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) (1)
Dec 9, 2024	275	NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/09/2024) (3)
Dec 4, 2024	272	NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (3)
Dec 4, 2024	273	MOTION to Withdraw as Attorney JENNIFER BROOKS CROZIER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4)
Dec 4, 2024	274	MOTION to Withdraw as Attorney ROCCO RECCE'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4)
Nov 15, 2024	271	ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. 394 , 395 ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024) (1)
Nov 14, 2024	268	MOTION to Withdraw as Attorney SEAN M. DOUGLASS' MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4)
Nov 14, 2024	269	MOTION to Withdraw as Attorney REBECCA CARTER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4)
Nov 14, 2024	270	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. for Amgen's Responses to Regeneron's Third Set of Requests for Production of Documents and Things (No. 27). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 11/14/2024) (2)
Oct 31, 2024	267	ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 378 ). Ms. Anderson shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 10/31/2024) (1)
Oct 30, 2024	266	MOTION to Withdraw as Attorney HAYLEE BERNAL ANDERSON'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 10/30/2024) (4)
Oct 22, 2024	265	ORDER of USCA for the Federal Circuit as to 344 in 1:24-md-03103-TSK-JPM Notice of Appeal and 258 in 1:24-cv-00039-TSK-JPM Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 10/22/2024) (3)
Oct 15, 2024	264	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Third Requests for Production of Documents and Things to Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 10/15/2024) (1)
Oct 1, 2024	263	REDACTED ORDER DENYING REGENERON'S MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 09/23/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 10/01/2024) (30)
Sep 27, 2024	262	RESPONSE to Motion re (27 in 1:24-cv-00053-TSK, 334 in 1:24-md-03103-TSK-JPM, 261 in 1:23-cv-00106-TSK-JPM, 266 in 1:23-cv-00097-TSK-JPM, 254 in 1:24-cv-00039-TSK-JPM, 278 in 1:23-cv-00094-TSK-JPM, 215 in 1:23-cv-00089-TSK-JPM) MOTION for Status Conference filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 09/27/2024) (5)
Sep 25, 2024	261	ORDER ISSUED AS PER CURIAM of USCA for the Federal Circuit as to 344 in 1:24-md-03103-TSK-JPM and 258 in 1:24-cv-00039-TSK-JPM Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. (snc) (Entered: 09/25/2024) (2)
Sep 24, 2024	259	Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) () (1)
Sep 24, 2024	260	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 344 in 1:24-md-03103-TSK-JPM and 258 in 1:24-cv-00039-TSK-JPM. Notice of Appeal filed by Regeneron Pharmaceuticals, Inc. USCA for the Federal Circuit Case Number: 2024-2351. (snc) (Entered: 09/24/2024) (4)
Sep 24, 2024	259	Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Attorney List) (25)
Sep 24, 2024	259	Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Docket Sheet) (30)
Sep 24, 2024	259	Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 344 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Additional attachment(s) added on 9/24/2024: # 4 Sealed Order) (snc). (Attachment 2 replaced on 9/24/2024) (snc). (Entered: 09/24/2024) (Notice of Appeal) (4)
Sep 23, 2024	258	Notice of Appeal* (1)
Sep 23, 2024	257	*SEALED*ORDER DENYING REGENERON'S MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 09/23/2024. (Copy to counsel for Regeneron and Amgen ONLY) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/23/2024) (0)
Sep 20, 2024	256	Memorandum in Opposition re (824 in 1:22-cv-00061-TSK-JPM, 327 in 1:24-md-03103-TSK-JPM) MOTION to Unseal Document Portions of the August 13, 2024 Hearing Transcript and Related Briefing filed by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 09/20/2024) (6)
Sep 16, 2024	255	ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., 190 Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., 203 Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) (3)
Sep 13, 2024	253	STIPULATION TO SUPPLEMENT PRELIMINARY INJUNCTION RECORD by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit A _ Approval Letter)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/13/2024) () (5)
Sep 13, 2024	254	MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) () (8)
Sep 13, 2024	253	STIPULATION TO SUPPLEMENT PRELIMINARY INJUNCTION RECORD by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit A _ Approval Letter)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/13/2024) (Exhibit A _ Approval Letter) (8)
Sep 13, 2024	254	MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. A) (6)
Sep 13, 2024	254	MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. B) (18)
Sep 13, 2024	254	MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. C) (30)
Sep 13, 2024	254	MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. D) (12)
Sep 12, 2024	252	ORDER granting 328 Motion for Leave to Appear Pro Hac Vice (Jeffrey A. Lamken) in case 1:24-md-03103-TSK-JPM; (250) Motion in 1:24-cv-00039-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 09/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/12/2024) (1)
Sep 11, 2024	250	MOTION for Leave to Appear Pro Hac Vice Jeffrey A. Lamken by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/11/2024) () (2)
Sep 11, 2024	251	Pro Hac Vice Filing fee: $ 200.00, receipt number 100003945. (For Jeffrey Lamken) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 09/11/2024) (0)
Sep 11, 2024	250	MOTION for Leave to Appear Pro Hac Vice Jeffrey A. Lamken by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 09/11/2024) (Proposed Order Proposed Order) (1)
Sep 3, 2024	249	ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) (1)
Aug 30, 2024	247	MOTION to Withdraw as Attorney RENEE M. GRIFFIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4)
Aug 30, 2024	248	MOTION to Withdraw as Attorney YI ZHANG'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4)
Aug 26, 2024	246	ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 318 ]. Signed by Chief District Judge Thomas S. Kleeh on 8/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(jb) (Entered: 08/26/2024) (1)
Aug 20, 2024	244	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) () (4)
Aug 20, 2024	244	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) (Attachment Memorandum in Support) (6)
Aug 20, 2024	244	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 08/20/2024) (Proposed Order) (1)
Aug 14, 2024	242	TRANSCRIPT of Proceedings held on 8/13/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 9/4/2024. Redacted Transcript Deadline set for 9/16/2024. Release of Transcript Restriction set for 11/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(ck) (Entered: 08/14/2024) (0)
Aug 14, 2024	243	SEALED TRANSCRIPT of Sealed Hearing held on 8/13/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(ck) (Entered: 08/14/2024) (0)
Aug 13, 2024	241	MINUTE ENTRY: *NOTICE* THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S. Kleeh. Oral Argument Hearing re 157 Morion held on 8/13/2024. (Court Reporter Cindy Knecht) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/13/2024) (0)
Aug 9, 2024	239	MOTION to Permit Entry to the Courthouse With Electronic Equipment by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/09/2024) () (4)
Aug 9, 2024	240	ORDER GRANTING DEFENDANT AMGEN INC.'S 311 MOTION TO PERMIT ENTRY TO THE COURTHOUSE WITH ELECTRONIC EQUIPMENT. Signed by Chief District Judge Thomas S. Kleeh on 08/09/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/09/2024) (1)
Aug 9, 2024	239	MOTION to Permit Entry to the Courthouse With Electronic Equipment by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McKitrick, Kaitlyn) (Entered: 08/09/2024) (Proposed Order Proposed Order) (1)
Aug 2, 2024	238	NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) () (4)
Aug 2, 2024	238	NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 23, 2024 Order ('572 patent)) (6)
Aug 2, 2024	238	NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 30, 2024 Judgment ('601 patent)) (4)
Aug 1, 2024	235	ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 298 , 303 . Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1)
Aug 1, 2024	236	ORDER granting 301 Motion to Withdraw as Attorney. Attorney Ashley Hardesty Odell terminated. Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1)
Aug 1, 2024	237	ORDER. Oral argument on Regeneron's motion 157 for preliminary injunction against Amgen is RESCHEDULED for August 13, 2024, from 9:00 a.m. until 11:00 a.m., at the Clarksburg, West Virginia, point of holding court. This is a change in location only. Signed by Chief District Judge Thomas S. Kleeh on 08/01/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 08/01/2024) (1)
Jul 31, 2024	232	MOTION to Withdraw as Attorney by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 07/31/2024) (3)
Jul 31, 2024	233	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) () (4)
Jul 31, 2024	233	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) (Attachment Memorandum in Support) (6)
Jul 31, 2024	233	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/31/2024) (Proposed Order) (1)
Jul 29, 2024	230	MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) () (3)
Jul 29, 2024	230	MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) (Memorandum in Support) (3)
Jul 29, 2024	230	MOTION for Leave to File UNDER SEAL - for Motion for Leave to File a Surreply by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/29/2024) (Proposed Order) (1)
Jul 26, 2024	229	ORDER. Oral argument on Regeneron's motion 157 for preliminary injunction against Amgen is CONTINUED until August 13, 2024, from 9:00 a.m. until 11:00 a.m., at the Elkins, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 07/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/26/2024) (1)
Jul 25, 2024	227	ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 287 , 289 . Signed by Chief District Judge Thomas S. Kleeh on 07/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (1)
Jul 25, 2024	228	ORDER. Oral argument on Regeneron's motion for preliminary injunction against Amgen 157 is SCHEDULED for August 6, 2024, between 10:00 a.m. and 12:00 p.m., at the Clarksburg, West Virginia, point of holding court. The parties SHALL email proposed orders on the preliminary injunction motion on or before August 9, 2024. Amgen's motion for guidance is DENIED AS MOOT [No. 283]. Signed by Chief District Judge Thomas S. Kleeh on 07/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (1)
Jul 25, 2024	N/A	Set/Reset Deadlines as to Oral Argument Hearing re: 157 motion set for 8/6/2024 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/25/2024) (0)
Jul 24, 2024	219	MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) () (3)
Jul 24, 2024	221	NOTICE of Appearance by Stuart A. McMillan on behalf of Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(McMillan, Stuart) (Entered: 07/24/2024) (1)
Jul 24, 2024	222	ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 279 , 282 . Signed by Chief District Judge Thomas S. Kleeh on 07/24/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/24/2024) (1)
Jul 24, 2024	223	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) () (4)
Jul 24, 2024	225	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) () (4)
Jul 24, 2024	225	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Attachment Memorandum in Support) (6)
Jul 24, 2024	225	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Proposed Order) (1)
Jul 24, 2024	223	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Attachment Memorandum in Support) (6)
Jul 24, 2024	223	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/24/2024) (Proposed Order) (1)
Jul 24, 2024	219	MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) (Memorandum in Support) (3)
Jul 24, 2024	219	MOTION for Leave to File UNDER SEAL - for Motion for Guidance by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/24/2024) (Proposed Order) (1)
Jul 22, 2024	216	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) () (3)
Jul 22, 2024	216	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) (Memorandum in Support) (3)
Jul 22, 2024	216	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/22/2024) (Proposed Order) (1)
Jul 15, 2024	215	Other Document REGENERON'S RESPONSE TO AMGEN'S REQUEST FOR ORAL ARGUMENT filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/15/2024) (5)
Jul 12, 2024	214	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. of Amgen's Responses to Regeneron's Second Set of Requests for Production of Documents and Things (Nos. 25-26). Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/12/2024) (2)
Jul 11, 2024	213	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of David Blackburn, Ph.D.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/11/2024) (1)
Jul 10, 2024	211	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Brian Heath. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/10/2024) (1)
Jul 10, 2024	212	NOTICE of Appearance by Karly King on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(King, Karly) (Entered: 07/10/2024) (1)
Jul 9, 2024	210	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Steven M. Chamow. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 07/09/2024) (1)
Jul 8, 2024	208	ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 227 , 229 , 234 . Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 07/08/2024) (1)
Jul 8, 2024	209	*SEALED* SEALED ORDER DENYING REGENERON'S MOTION 199 TO COMPEL. Signed by Magistrate Judge James P. Mazzone on 07/08/2024. (Copy to counsel for Regeneron and Amgen only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) Modified to add order title on 7/8/2024 (snc). (Entered: 07/08/2024) (0)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) () (5)
Jul 3, 2024	205	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) () (3)
Jul 3, 2024	205	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) (Attachment Memorandum In Support) (3)
Jul 3, 2024	205	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memorandum In Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Labbe, John) (Entered: 07/03/2024) (Proposed Order) (1)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 1) (3)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 2) (2)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 3) (3)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 4) (2)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 5) (4)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 6) (2)
Jul 3, 2024	204	REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 7) (2)
Jul 2, 2024	203	SEALED TRANSCRIPT of Sealed Hearing held on 7/1/2024, before Judge Mazzone. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968.. (ck) (Entered: 07/02/2024) (0)
Jul 1, 2024	200	ORDER GRANTING MOTION 217 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 7/1/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM. (jb) (Copy to counsel) (Entered: 07/01/2024) (1)
Jun 28, 2024	198	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) () (2)
Jun 28, 2024	202	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG. USCA for the Federal Circuit USCA Case Number: 2024-2019. Case Manager: M. Ames. (Clerk confirmed with Federal Circuit (J. Phillips) that this second appeal was opened in error and that a termination letter would be issued.) (dk) (Entered: 07/01/2024) (4)
Jun 28, 2024	198	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) (Attachment Memo) (2)
Jun 28, 2024	198	MOTION for Leave to File UNDER SEAL by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/28/2024) (Proposed Order) (1)
Jun 26, 2024	196	*SEALED*SEALED ORDER SETTING DEADLINES AND ORAL ARGUMENT/EVIDENTIARY HEARING. Signed by Magistrate Judge James P. Mazzone on 06/26/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/26/2024) (0)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) () (8)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 1) (5)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 2) (7)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 3) (6)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 4) (3)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 5) (4)
Jun 26, 2024	197	RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Proposed Order) (4)
Jun 25, 2024	194	ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 198 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/25/2024) (1)
Jun 25, 2024	195	ORDER OF REFERRAL. The motion 199 is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 06/25/2024. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/25/2024) (1)
Jun 24, 2024	192	MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) () (4)
Jun 24, 2024	192	MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Memorandum of Law in Support) (6)
Jun 24, 2024	192	MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Memorandum of Law in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Ruby, Steven) (Entered: 06/24/2024) (Proposed Order) (1)
Jun 17, 2024	191	NOTICE of Appearance by Ryan Moore on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Moore, Ryan) (Entered: 06/17/2024) (1)
Jun 14, 2024	188	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Sean Sheridan. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1)
Jun 14, 2024	189	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Kevin Clark. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1)
Jun 14, 2024	190	CERTIFICATE OF SERVICE by Amgen, Inc., Amgen, Inc. Notice of Deposition of Bernhardt Trout. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/14/2024) (1)
Jun 13, 2024	186	Withdrawal of Amgen Inc.'s Motion to Compel Other Document re (125 in 1:24-cv-00039-TSK-JPM) MOTION to Compel filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/13/2024) () (4)
Jun 13, 2024	187	ORDER DENYING AS MOOT AMGEN INC.'S MOTION TO COMPEL. In light of Amgen Inc's withdrawal of its Motion to Compel, the Motion (ECF Nos. 21 and 125 is DENIED AS MOOT. The hearing currently set for June 20, 2024, is CANCELLED. Signed by Magistrate Judge James P. Mazzone on 06/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/13/2024) (1)
Jun 13, 2024	186	Withdrawal of Amgen Inc.'s Motion to Compel Other Document re (125 in 1:24-cv-00039-TSK-JPM) MOTION to Compel filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Odell, Ashley) (Entered: 06/13/2024) (Exhibit 1) (4)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) () (4)
Jun 12, 2024	185	CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Second Requests for Production of Documents and Things to Amgen, Inc. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM(Pogue, David) (Entered: 06/12/2024) (1)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Supplement Memo ISO) (8)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Proposed Order) (3)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 1) (2)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 2) (5)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 3) (9)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 4) (13)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 5) (3)
Jun 12, 2024	184	MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 6) (5)
Jun 11, 2024	183	ORDER SETTING DEADLINES AND ORAL ARGUMENT/EVIDENTIARY HEARING re 21 Motion to Compel. (Responses due by 6/14/2024, Replies due by 6/18/2024., Oral Argument/Evidentiary Hearing set for 6/20/2024 at 10:00 AM in Wheeling Magistrate Judge Courtroom, 4th Floor before Magistrate Judge James P. Mazzone.) Signed by Magistrate Judge James P. Mazzone on 06/11/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM (snc) (Entered: 06/11/2024) (1)
Jun 10, 2024	181	ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 156 ). Signed by Chief District Judge Thomas S. Kleeh on 06/10/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 06/10/2024) (1)
Jun 10, 2024	182	ORDER OF REFERRAL. The motion 21 is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 06/10/2024. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 06/10/2024) (1)
Jun 7, 2024	179	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) () (4)
Jun 7, 2024	179	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) (Attachment Memorandum in Support) (6)
Jun 7, 2024	179	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 06/07/2024) (Proposed Order) (1)
May 31, 2024	178	Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) () (14)
May 31, 2024	178	Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix A - Regeneron's Filings) (30)
May 31, 2024	178	Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix B - Amgen's Filings) (30)
May 31, 2024	178	Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix C - Mylan/Biocon's Filings) (30)
May 31, 2024	178	Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis) (30)
May 29, 2024	176	STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order Stipulated Protective Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Pogue, David) (Entered: 05/29/2024) () (4)
May 29, 2024	177	STIPULATED PROTECTIVE ORDER. Signed by Chief District Judge Thomas S. Kleeh on 05/29/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/29/2024) (30)
May 29, 2024	176	STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order Stipulated Protective Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Pogue, David) (Entered: 05/29/2024) (Proposed Order Stipulated Protective Order) (30)
May 28, 2024	175	ORDER. Regeneron's Motion to Partially Withdraw Motions for Preliminary Injunction is GRANTED 119 . The portions of Regeneron's preliminary injunction motions that do not relate to the 865 patent are hereby WITHDRAWN. Amgen's motion for clarification on this issue is GRANTED 142 . The Court AMENDS the preliminary injunction briefing schedule with respect to Amgen. Signed by Chief District Judge Thomas S. Kleeh on 05/28/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/28/2024) (2)
May 24, 2024	172	ORDER SETTING BRIEFING SCHEDULE WITH RESPECT TO ANY MOTION FOR PRELIMINARY INJUNCTION AGAINST AMGEN. Motion, on or before June 7, 2024; Response, on or before June 21, 2024; Reply, on or before July 3, 2024. Signed by Chief District Judge Thomas S. Kleeh on 05/24/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/24/2024) (1)
May 24, 2024	173	Pro Hac Vice Filing fee: $ 600.00, receipt number 100003909. (For Damron, Carey and Franks) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/24/2024) (0)
May 24, 2024	174	Emergency MOTION to Clarify Whether Regeneron's Preliminary Injunction Motion Will Be Limited to the '865 Patent by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/24/2024) (4)
May 23, 2024	168	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jordan L. Damron Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1)
May 23, 2024	169	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Michael W. Carey Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1)
May 23, 2024	170	Pro Hac Vice Filing fee: $ 400.00, receipt number 100003908. (For Attorneys E. Weiswasser and A. Goldsmith) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/23/2024) (0)
May 23, 2024	171	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Raymond S. Franks II Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/23/2024) (1)
May 22, 2024	166	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Elizabeth S. Weiswasser Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/22/2024) (1)
May 22, 2024	167	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Andrew E. Goldsmith Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/22/2024) (1)
May 21, 2024	163	ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 22 , 100 , 101 . Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK (snc) (Entered: 05/21/2024) (1)
May 21, 2024	164	ORDER REGARDING LIAISON COUNSEL. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/21/2024) (2)
May 21, 2024	165	ORDER DENYING CERTAIN MOTIONS AS MOOT. Regeneron's motion for guidance 36 and Amgen's motion requesting an expedited status conference 20 are DENIED AS MOOT. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) Modified to unseal on 5/21/2024; Order was sealed in error. NEF regen. (dk). (Entered: 05/21/2024) (1)
May 20, 2024	160	ORDER. The parties are DIRECTED to file, on or before May 31, 2024, written proposals indicating which matters are appropriate for collective pretrial consideration and disposition while the case is designated as an MDL. Signed by Chief District Judge Thomas S. Kleeh on 5/20/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 05/20/2024) (1)
May 20, 2024	161	MOTION to Withdraw Appearance of Siegmund Gutman by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/20/2024) () (3)
May 20, 2024	162	ORDER GRANTING AMGEN INC.'S 113 and 161 MOTION FOR WITHDRAWAL OF APPEARANCE AND TERMINATION OF CM/ECF RECORD OF SIEGMUND GUTMAN. Siegmund Gutman terminated from 1:24-md-3103 and 1:24-cv-39. Signed by Chief District Judge Thomas S. Kleeh on 5/20/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (jb) (Entered: 05/20/2024) (1)
May 20, 2024	161	MOTION to Withdraw Appearance of Siegmund Gutman by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/20/2024) (Proposed Order) (2)
May 17, 2024	158	MINUTE ENTRY: *NOTICE* THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh, Scheduling Conference held on 5/17/2024. (Court Reporter Cindy Knecht) Associated Cases: 1:24-md-03103-TSK et al. (dk) (Entered: 05/17/2024) (0)
May 17, 2024	159	TRANSCRIPT of status conference held on 5/17/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 6/7/2024. Redacted Transcript Deadline set for 6/17/2024. Release of Transcript Restriction set for 8/15/2024. Associated Cases: 1:24-md-03103-TSK et al.(ck) (Entered: 05/17/2024) (22)
May 16, 2024	137	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Mary Charlotte Y. Carroll Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	138	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jennifer Melien Brooks Crozier Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	139	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Anish Desai Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	140	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Teagan J. Gregory Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	141	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Jacob E. Hartman Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	142	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Sven E. Henningson III Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	143	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Natalie C. Kennedy Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	144	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Grace W. Knofczynski Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	145	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Rhochelle Krawetz Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	146	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Kathryn Leicht Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	147	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Zhen Lin Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	148	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Shaun P. Mahaffy Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	149	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Priyata Patel Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	150	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Christopher Pepe Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	151	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Alyssa J. Picard Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	152	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Rocco Recce Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	153	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Matthew D. Sieger Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	154	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Kellie C. Van Beck Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	155	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Tom Yu Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	156	NOTICE by Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. Notice of Appearance of Yi Zhang Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Ruby, Steven) (Entered: 05/16/2024) (1)
May 16, 2024	157	Pro Hac Vice Filing fee: $ 4000.00, receipt number 100003903. (For Attorneys Carroll, Crozier, Desai, Gregory, Hartman, Henningson, Kennedy, Knofczynski, Krawetz, Leicht, Lin, Mahaffy, Patel, Pepe, Picard, Recce, Sieger, Van Beck, Yu and Zhang) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/16/2024) (0)
May 14, 2024	136	Pro Hac Vice Filing fee: $ 2000.00, receipt number 100003902. (For Attorneys A. Pan, A. Trask, A. Argall, D, Berl, E. Oberwetter, H. Anderson, J. Beazley, K. Kayali, R. Griffin, and T. Fletcher) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/14/2024) (0)
May 10, 2024	135	NOTICE by Regeneron Pharmaceuticals, Inc. Joint Notice of Pending Motions Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/10/2024) (14)
May 9, 2024	134	NOTICE by Amgen, Inc., Amgen, Inc. of Attorney Appearance of Chanson Chang Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/09/2024) (1)
May 7, 2024	133	REPLY to Response to Motion re (207 in 1:23-cv-00094-TSK-JPM, 217 in 1:23-cv-00097-TSK-JPM, 168 in 1:23-cv-00089-TSK-JPM, 131 in 1:24-cv-00039-TSK, 754 in 1:22-cv-00061-TSK-JPM, 36 in 1:24-md-03103-TSK, 189 in 1:23-cv-00106-TSK-JPM) MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/07/2024) (4)
May 3, 2024	130	Filing fee: $ 800.00, receipt number 100003889. (For Attorneys B. Postal, J. Nock, E. Figg and J. Hynds) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) Modified docket text on 5/3/2024 (snc). (Entered: 05/03/2024) (0)
May 3, 2024	131	MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/03/2024) (6)
May 3, 2024	132	Filing fee: $ 600.00, receipt number 100003890 (For Attorneys E. Agovino, P. Pelletier and A. Whiteford) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (snc) (Entered: 05/03/2024) (0)
May 2, 2024	128	Filing fee: $ 600.00, receipt number 100003887. (For Attorneys K. Flowers, T. Burns and J. Labbe) Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(snc) (Entered: 05/02/2024) (0)
May 2, 2024	129	Amgen's Withdrawal of Its Motion Requesting an Expedited Status Conference Other Document filed by Amgen, Inc., Amgen, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 05/02/2024) (3)
Apr 26, 2024	127	PRETRIAL ORDER #1: INITIAL SCHEDULING CONFERENCE. Scheduling Conference is set for 5/17/2024 11:00 AM by Zoom Videoconference before Chief District Judge Thomas S. Kleeh. Signed by Chief District Judge Thomas S. Kleeh on 4/26/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 04/26/2024) (10)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) () (2)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Attachment Memo ISO) (22)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 1) (2)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 2) (30)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 3) (8)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 4) (11)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 5) (5)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 6) (5)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 7) (1)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 8) (1)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 9) (1)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Exhibit 10) (7)
Apr 25, 2024	125	MOTION to Compel by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Attachment Memo ISO, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/25/2024) (Proposed Order) (3)
Apr 24, 2024	123	ORDER GRANTING AMGEN INC.S MOTION FOR LEAVE TO FILE ITS MOTION REQUESTING AN EXPEDITED STATUS CONFERENCE UNDER SEAL. Amgen shall promptly file its Motion for Leave to File Its Motion Requesting an Expedited Status Conference under seal. Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK (dk) (Entered: 04/24/2024) (1)
Apr 19, 2024	122	NOTICE of Appearance by Kaitlyn N. McKitrick on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(McKitrick, Kaitlyn) (Entered: 04/19/2024) (1)
Apr 18, 2024	119	NOTICE of Appearance by Ashley Hardesty Odell on behalf of Amgen, Inc., Amgen, Inc. Associated Cases: 1:24-md-03103-TSK, 1:24-cv-00039-TSK(Odell, Ashley) (Entered: 04/18/2024) (1)
Apr 18, 2024	120	MOTION for Leave to Appear of David R. Pogue by Regeneron Pharmaceuticals, Inc.. (Pogue, David) (Entered: 04/18/2024) (2)
Apr 17, 2024	116	Case transferred in from District of California Central; Case Number 2:24-cv-00264. (kac) (Entered: 04/17/2024) () (23)
Apr 17, 2024	117	MOTION for Leave to Appear Pro Hac Vice of Elizabeth S. Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) () (2)
Apr 17, 2024	118	MOTION for Leave to Appear Pro Hac Vice of Andrew E. Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) () (2)
Apr 17, 2024	117	MOTION for Leave to Appear Pro Hac Vice of Elizabeth S. Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Exhibit A-WVSB Receipt) (2)
Apr 17, 2024	117	MOTION for Leave to Appear Pro Hac Vice of Elizabeth S. Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Attachment A) (1)
Apr 17, 2024	117	MOTION for Leave to Appear Pro Hac Vice of Elizabeth S. Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Proposed Order) (1)
Apr 17, 2024	118	MOTION for Leave to Appear Pro Hac Vice of Andrew E. Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Exhibit A-WVSB Receipt) (2)
Apr 17, 2024	118	MOTION for Leave to Appear Pro Hac Vice of Andrew E. Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Attachment A) (1)
Apr 17, 2024	118	MOTION for Leave to Appear Pro Hac Vice of Andrew E. Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Attachment B) (1)
Apr 17, 2024	118	MOTION for Leave to Appear Pro Hac Vice of Andrew E. Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 04/17/2024) (Proposed Order) (1)
Apr 15, 2024	113	Notice of Appearance or Withdrawal of Counsel: for attorney Scott Patrick Cooper counsel for Defendant Amgen, Inc.. Scott Patrick Cooper is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendant Amgen Inc.. (Cooper, Scott) [Transferred from California Central on 4/17/2024.] (Entered: 04/15/2024) (2)
Apr 15, 2024	114	Notice of Appearance or Withdrawal of Counsel: for attorney Shawn Scott Ledingham, Jr counsel for Defendant Amgen, Inc.. Shawn Scott Ledingham, Jr. is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendant Amgen Inc.. (Ledingham, Shawn) [Transferred from California Central on 4/17/2024.] (Entered: 04/15/2024) (2)
Apr 15, 2024	115	Transfer Order from the United States Judicial Panel on Multidistrict Litigation, MDL 3101, transferring case to USDC, Northern District of West Virginia and assigned to Honorable Thomas S. Kleeh. Case transferred electronically. (MD JS-6. Case Terminated.) (yl) [Transferred from California Central on 4/17/2024.] (Entered: 04/16/2024) (5)
Apr 12, 2024	112	NOTICE of Decision: Notice of Ruling by Judicial Panel on Multidistrict Litigation filed by Defendant Amgen, Inc.. (Attachments: # 1 Transfer Order)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 04/12/2024) () (2)
Apr 12, 2024	112	NOTICE of Decision: Notice of Ruling by Judicial Panel on Multidistrict Litigation filed by Defendant Amgen, Inc.. (Attachments: # 1 Transfer Order)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 04/12/2024) (Transfer Order) (5)
Apr 10, 2024	110	REQUEST TO WITHDRAW ATTORNEY Anthony R. Bisconti as counsel of record filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 04/10/2024) () (2)
Apr 10, 2024	111	ORDER by Judge John W. Holcomb: Granting 110 Plaintiff Regeneron Pharmaceuticals, Inc. Request to Substitute Attorney Matthew Donald Umhofer, Umhoffer Mitchell & King LLP as attorney of record instead of Anthony R. Bisconti, Bienert Katzman Littrell Williams LLP (es) [Transferred from California Central on 4/17/2024.] (Entered: 04/10/2024) (1)
Apr 10, 2024	110	REQUEST TO WITHDRAW ATTORNEY Anthony R. Bisconti as counsel of record filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 04/10/2024) (Proposed Order) (1)
Apr 9, 2024	109	Notice of Appearance or Withdrawal of Counsel: for attorney Adam Pan counsel for Plaintiff Regeneron Pharmaceuticals, Inc.. Adding Adam Pan as counsel of record for Regeneron Pharmaceuticals, Inc. for the reason indicated in the G-123 Notice. Filed by plaintiff Regeneron Pharmaceuticals, Inc.. (Attorney Adam Pan added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Pan, Adam) [Transferred from California Central on 4/17/2024.] (Entered: 04/09/2024) (2)
Apr 8, 2024	107	ORDER GRANTING PLAINTIFF REGENERON PHARMACEUTICALS, INC.'S APPLICATION FOR LEAVE TO FILE JOINT STATUS REPORT UNDER SEAL 105 by Judge John W. Holcomb. Accordingly, it is hereby ORDERED as follows: 1. The Application is GRANTED. 2. The parties may file an unredacted version of the Joint Status Report (ECF 105-3) under seal. (rolm) [Transferred from California Central on 4/17/2024.] (Entered: 04/08/2024) (2)
Apr 8, 2024	108	SEALED DOCUMENT Joint Status Report re Order on Motion for Leave to File Document Under Seal, 107 filed by Plaintiff Regeneron Pharmaceuticals, Inc..(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/08/2024) (0)
Apr 5, 2024	105	APPLICATION to file document Joint Status Report under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Jonas P. Mann in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document, # 4 Proof of Service)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) () (3)
Apr 5, 2024	106	SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Joint Status Report under seal 105 filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Unredacted Document Joint Status Report)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) (0)
Apr 5, 2024	105	APPLICATION to file document Joint Status Report under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Jonas P. Mann in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document, # 4 Proof of Service)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) (Declaration of Jonas P. Mann in support of Application to Seal) (2)
Apr 5, 2024	105	APPLICATION to file document Joint Status Report under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Jonas P. Mann in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document, # 4 Proof of Service)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) (Proposed Order) (2)
Apr 5, 2024	105	APPLICATION to file document Joint Status Report under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Jonas P. Mann in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document, # 4 Proof of Service)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) (Redacted Document) (14)
Apr 5, 2024	105	APPLICATION to file document Joint Status Report under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Jonas P. Mann in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document, # 4 Proof of Service)(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/05/2024) (Proof of Service) (6)
Apr 1, 2024	103	NOTICE of Appearance filed by attorney Matthew Donald Umhofer on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attorney Matthew Donald Umhofer added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Umhofer, Matthew) [Transferred from California Central on 4/17/2024.] (Entered: 04/01/2024) (2)
Apr 1, 2024	104	NOTICE of Appearance filed by attorney Jonas Palmer Mann on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attorney Jonas Palmer Mann added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Mann, Jonas) [Transferred from California Central on 4/17/2024.] (Entered: 04/01/2024) (2)
Mar 27, 2024	102	(IN CHAMBERS) ORDER by Judge John W. Holcomb: On the Court's own motion, it is hereby ORDERED as follows: (1) the Scheduling Conference is CONTINUED from Friday, April 5, 2024, to Friday, April 19, 2024, at 11:00 a.m. in Courtroom 9D of the Ronald Reagan Federal Building and U.S. Courthouse, 411 W. 4th Street, Santa Ana, California; (2) the parties are DIRECTED to file a Joint Status Report, no later than April 5, 2024, providing the parties' proposed schedule for preliminary injunction proceeding briefing or, if the parties cannot agree, providing each party's proposed schedule and its objections to the other party's proposed schedule; and (3) the parties are DIRECTED to file a Notice of Decision within 48 hours after an order issues regarding the motion to transfer, which is scheduled to be heard by the Judicial Panel on Multidistrict Litigation on March 28, 2024. IT IS SO ORDERED. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 03/27/2024) (0)
Feb 26, 2024	99	ORDER by Judge John W. Holcomb: Granting 97 Plaintiff Regeneron Pharmaceuticals Inc.'s APPLICATION for Leave to File Answer to Counterclaims Under Seal. SEE DOCUMENT FOR FURTHER INFORMATION. (twdb) [Transferred from California Central on 4/17/2024.] (Entered: 02/26/2024) (3)
Feb 26, 2024	100	Redacted ANSWER to Answer to Complaint (Attorney Civil Case Opening),,, Counterclaim,, 90 to Amgen Inc.'s Counterclaims filed by Plaintiff Regeneron Pharmaceuticals, Inc..(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/26/2024) (30)
Feb 26, 2024	101	SEALED DOCUMENT Plaintiff Regeneron Pharmaceuticals Inc.'s Answer to Defendant Amgen Inc.'s Counterclaims re Answer to Complaint (Attorney Civil Case Opening),,, Counterclaim,, 90 , Order on Motion for Leave to File Document Under Seal 99 filed by Plaintiff Regeneron Pharmaceuticals, Inc..(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/26/2024) (0)
Feb 23, 2024	97	APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document Regeneron's Answer to Amgen's Counterclaims, # 4 Certificate of Service)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) () (5)
Feb 23, 2024	98	SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal 97 filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Unredacted Document Regeneron's Answer to Amgen's Counterclaims)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) (0)
Feb 23, 2024	97	APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document Regeneron's Answer to Amgen's Counterclaims, # 4 Certificate of Service)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) (Declaration of Anthony R. Bisconti in support of Application to Seal) (3)
Feb 23, 2024	97	APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document Regeneron's Answer to Amgen's Counterclaims, # 4 Certificate of Service)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) (Proposed Order) (3)
Feb 23, 2024	97	APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document Regeneron's Answer to Amgen's Counterclaims, # 4 Certificate of Service)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) (Redacted Document Regeneron's Answer to Amgen's Counterclaims) (30)
Feb 23, 2024	97	APPLICATION to file document Regeneron's Answer to Amgen's Counterclaims under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti in support of Application to Seal, # 2 Proposed Order, # 3 Redacted Document Regeneron's Answer to Amgen's Counterclaims, # 4 Certificate of Service)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 02/23/2024) (Certificate of Service) (4)
Feb 12, 2024	96	Mail Returned addressed to Teagan Gregory re Pro Hac Vice Application Due (G-109) - 23 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/16/2024) (5)
Feb 8, 2024	95	Mail Returned addressed to Teagan Gregory re Pro Hac Vice Application Due (G-109) 27 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/15/2024) (3)
Feb 7, 2024	89	SEALED DOCUMENT Amgen Inc.'s Answer to Complaint and Counterclaims re Order on Motion for Leave to File Document Under Seal 88 filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (0)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) () (30)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit A) (3)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit B) (3)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit C) (11)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit D) (3)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit E) (13)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit F) (10)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit G) (10)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit H) (30)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit I) (7)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit J) (7)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit K) (10)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit L) (11)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit M) (12)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit N) (7)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit O) (9)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit P) (10)
Feb 7, 2024	90	ANSWER to Complaint (Attorney Civil Case Opening), 1 Amgen Inc.'s Answer to Complaint and, COUNTERCLAIM against Amgen, Inc. filed by Defendant Amgen, Inc.. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Exhibit Exhibit C, # 4 Exhibit Exhibit D, # 5 Exhibit Exhibit E, # 6 Exhibit Exhibit F, # 7 Exhibit Exhibit G, # 8 Exhibit Exhibit H, # 9 Exhibit Exhibit I, # 10 Exhibit Exhibit J, # 11 Exhibit Exhibit K, # 12 Exhibit Exhibit L, # 13 Exhibit Exhibit M, # 14 Exhibit Exhibit N, # 15 Exhibit Exhibit O, # 16 Exhibit Exhibit P, # 17 Exhibit Exhibit Q)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/07/2024) (Exhibit Exhibit Q) (8)
Feb 6, 2024	78	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Eric M. Agovino to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 64 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	79	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Thomas R. Burns to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 65 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	80	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Edward A. Figg to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 66 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	81	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Joseph A. Hynds to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 67 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	82	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney John R. Labbe to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 68 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	83	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Kevin M. Flowers to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 69 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	84	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Jennifer P. Nock to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 70 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	85	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Pauline M. Pelletier to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 71 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	86	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Brett A. Postal to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. 72 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (0)
Feb 6, 2024	92	Mail Returned addressed to Jennalee Bearley re Pro Hac Vice Application Due (G-109) 15 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/08/2024) (5)
Feb 5, 2024	76	Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration of John R. Labbe, # 2 Proposed Order, # 3 Proof of Service, # 4 Redacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) () (5)
Feb 5, 2024	77	SEALED DECLARATION IN SUPPORT OF Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal 76 filed by Defendant Amgen, Inc.. (Attachments: # 1 Unredacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) (0)
Feb 5, 2024	87	ORDER GRANTING APPLICATION OF AMGEN INC. FOR LEAVE TO FILE ANSWER TO COMPLAINT AND COUNTERCLAIMS UNDER SEAL 74 by Judge John W. Holcomb. The Application is GRANTED. The following portions of Amgen Inc.s Answer to Complaint and Counterclaims shall be sealed: (See document for further details) (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (2)
Feb 5, 2024	88	ORDER GRANTING CORRECTED APPLICATION OF AMGEN INC. FOR LEAVE TO FILE ANSWER TO COMPLAINT AND COUNTERCLAIMS 76 UNDER SEAL by Judge John W. Holcomb. The application is GRANTED. (See document for further details) (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/06/2024) (3)
Feb 5, 2024	91	Mail Returned addressed to Eilen Oberwetter re Pro Hac Vice Application Due (G-109) - optional html form, 13 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/08/2024) (5)
Feb 5, 2024	93	Mail Returned addressed to Arthur Argal re Pro Hac Vice Application Due (G-109) 27 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/15/2024) (3)
Feb 5, 2024	76	Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration of John R. Labbe, # 2 Proposed Order, # 3 Proof of Service, # 4 Redacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) (Declaration of John R. Labbe) (3)
Feb 5, 2024	76	Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration of John R. Labbe, # 2 Proposed Order, # 3 Proof of Service, # 4 Redacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) (Proposed Order) (3)
Feb 5, 2024	76	Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration of John R. Labbe, # 2 Proposed Order, # 3 Proof of Service, # 4 Redacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) (Proof of Service) (4)
Feb 5, 2024	76	Corrected APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration of John R. Labbe, # 2 Proposed Order, # 3 Proof of Service, # 4 Redacted Version of Answer & Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/05/2024) (Redacted Version of Answer & Counterclaims) (30)
Feb 2, 2024	64	APPLICATION of Non-Resident Attorney Eric M. Agovino to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36845678) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (5)
Feb 2, 2024	65	APPLICATION of Non-Resident Attorney Thomas R. Burns to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36845950) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (6)
Feb 2, 2024	66	APPLICATION of Non-Resident Attorney Edward A. Figg to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846076) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (4)
Feb 2, 2024	67	APPLICATION of Non-Resident Attorney Joseph A. Hynds to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846226) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (5)
Feb 2, 2024	68	APPLICATION of Non-Resident Attorney John R. Labbe to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846337) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (4)
Feb 2, 2024	69	APPLICATION of Non-Resident Attorney Kevin M. Flowers to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846510) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (4)
Feb 2, 2024	70	APPLICATION of Non-Resident Attorney Jennifer P. Nock to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846636) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (5)
Feb 2, 2024	71	APPLICATION of Non-Resident Attorney Pauline M. Pelletier to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846774) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (6)
Feb 2, 2024	72	APPLICATION of Non-Resident Attorney Brett A. Postal to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846894) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) () (5)
Feb 2, 2024	73	Notice of Appearance or Withdrawal of Counsel: for attorney Siegmund Y Gutman counsel for Defendant Amgen, Inc.. Adding Wendy Whiteford as counsel of record for Amgen Inc for the reason indicated in the G-123 Notice. Filed by Defendant Amgen Inc. (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (2)
Feb 2, 2024	74	APPLICATION to file document Answer to Complaint and Counterclaims under seal filed by Defendant Amgen, Inc.. (Attachments: # 1 Declaration Of John R Labbe In Support Of Application Of Amgen Inc. For Leave To File Answer To Complaint And Counterclaims Under Seal, # 2 Proposed Order Granting Application Of Amgen Inc. For Leave To File Answer To Complaint And Counterclaims Under Seal, # 3 Proof of Service, # 4 Redacted Document Amgen Inc.'s Answer to Complaint and Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (0)
Feb 2, 2024	75	SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Answer to Complaint and Counterclaims under seal 74 filed by Defendant Amgen, Inc.. (Attachments: # 1 Unredacted Document Amgen Inc.'s Answer to Complaint and Counterclaims)(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (0)
Feb 2, 2024	94	Mail Returned addressed to Matthew Spieger re Pro Hac Vice Application Due (G-109) 32 (yl) [Transferred from California Central on 4/17/2024.] (Entered: 02/15/2024) (3)
Feb 2, 2024	70	APPLICATION of Non-Resident Attorney Jennifer P. Nock to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846636) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	68	APPLICATION of Non-Resident Attorney John R. Labbe to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846337) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	64	APPLICATION of Non-Resident Attorney Eric M. Agovino to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36845678) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	66	APPLICATION of Non-Resident Attorney Edward A. Figg to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846076) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR) (1)
Feb 2, 2024	65	APPLICATION of Non-Resident Attorney Thomas R. Burns to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36845950) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (2)
Feb 2, 2024	67	APPLICATION of Non-Resident Attorney Joseph A. Hynds to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846226) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	69	APPLICATION of Non-Resident Attorney Kevin M. Flowers to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846510) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	71	APPLICATION of Non-Resident Attorney Pauline M. Pelletier to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846774) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Feb 2, 2024	72	APPLICATION of Non-Resident Attorney Brett A. Postal to Appear Pro Hac Vice on behalf of Defendant Amgen, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36846894) filed by Defendant Amgen, Inc.. (Attachments: # 1 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 02/02/2024) (Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEA) (1)
Jan 30, 2024	63	Notice of Appearance or Withdrawal of Counsel: for attorney Scott Patrick Cooper counsel for Defendant Amgen, Inc.. Adding Scott P. Cooper as counsel of record for Amgen Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Amgen Inc.. (Attorney Scott Patrick Cooper added to party Amgen, Inc.(pty:dft))(Cooper, Scott) [Transferred from California Central on 4/17/2024.] (Entered: 01/30/2024) (2)
Jan 25, 2024	61	PROOF OF SERVICE filed by Plaintiff Regeneron Pharmaceuticals, Inc., re Initial Order upon Filing of Complaint - form only 48 served on 01/25/2024. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/25/2024) (4)
Jan 25, 2024	62	Notice of Appearance or Withdrawal of Counsel: for attorney Siegmund Y Gutman counsel for Defendant Amgen, Inc.. Adding Siegmund Y. Gutman as counsel of record for Amgen Inc. for the reason indicated in the G-123 Notice. Filed by DEFENDANT Amgen Inc.. (Attorney Siegmund Y Gutman added to party Amgen, Inc.(pty:dft))(Gutman, Siegmund) [Transferred from California Central on 4/17/2024.] (Entered: 01/25/2024) (2)
Jan 24, 2024	53	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Arthur J. Argall, III to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 41 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	54	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Jennalee N. Beazley to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 42 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	55	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Haylee Bernal Anderson to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 43 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	56	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Renee M. Griffin to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 44 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	57	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Kathryn S. Kayali to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 45 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	58	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Ellen E. Oberwetter to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 46 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 24, 2024	59	Text Only ORDER GRANTING APPLICATION of Non-Resident Attorney Andrew V. Trask to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. 47 by Judge John W. Holcomb. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 23, 2024	48	STANDING ORDER by Judge John W. Holcomb. (cla) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (17)
Jan 23, 2024	49	APPLICATION to file document Dkt. No. 37-2 under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti, # 2 Declaration of Leah Thompson, # 3 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) () (12)
Jan 23, 2024	50	NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney Renee M. Griffin to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771671) 44 . The following error(s) was/were found: Case number incomplete; missing initials of Judge. (ak) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (1)
Jan 23, 2024	51	MINUTES (IN CHAMBERS) ORDER GRANTING IN PART AND DENYING IN PART PLAINTIFF'S EX PARTE APPLICATION 38 by Judge John W. Holcomb. The Court ORDERS as follows: The Application is GRANTED in part, to the extent it requests setting a preliminary injunction proceeding schedule, and the Application is DENIED in part, to the extent it requests the specific schedule proposed by Regeneron. The Court SETS a Scheduling Conference on April 5, 2024, at 11:00 a.m. (SEE DOCUMENT FOR FURTHER DETAILS.) (rolm) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (3)
Jan 23, 2024	52	ORDER PERMANENTLY SEALING DKT. NO. 37-2 49 by Judge John W. Holcomb. Accordingly, it is hereby ORDERED as follows: 1. The Application is GRANTED. 2. The docket entry reflected as Dkt. No. 37-2 in this case shall be permanently sealed, and all public access thereto shall be restricted pending further order of this Court. 3. The Clerk is DIRECTED to take all steps necessary to seal and restrict public access to Dkt. No. 37-2 on the docket in this case. (rolm) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (2)
Jan 23, 2024	60	FOR COURT USE ONLY: STATISTICAL CORRECTION GRANTING 37 re Order 51 . (yl) [Transferred from California Central on 4/17/2024.] (Entered: 01/24/2024) (0)
Jan 23, 2024	49	APPLICATION to file document Dkt. No. 37-2 under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti, # 2 Declaration of Leah Thompson, # 3 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (Declaration of Anthony R. Bisconti) (7)
Jan 23, 2024	49	APPLICATION to file document Dkt. No. 37-2 under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti, # 2 Declaration of Leah Thompson, # 3 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (Declaration of Leah Thompson) (6)
Jan 23, 2024	49	APPLICATION to file document Dkt. No. 37-2 under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Anthony R. Bisconti, # 2 Declaration of Leah Thompson, # 3 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/23/2024) (Proposed Order) (2)
Jan 22, 2024	41	APPLICATION of Non-Resident Attorney Arthur J. Argall, III to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771536) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (6)
Jan 22, 2024	42	APPLICATION of Non-Resident Attorney Jennalee N. Beazley to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771606) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (4)
Jan 22, 2024	43	APPLICATION of Non-Resident Attorney Haylee Bernal Anderson to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771649) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (4)
Jan 22, 2024	44	APPLICATION of Non-Resident Attorney Renee M. Griffin to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771671) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (4)
Jan 22, 2024	45	APPLICATION of Non-Resident Attorney Kathryn S. Kayali to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771690) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (6)
Jan 22, 2024	46	APPLICATION of Non-Resident Attorney Ellen E. Oberwetter to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771708) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (5)
Jan 22, 2024	47	APPLICATION of Non-Resident Attorney Andrew V. Trask to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771724) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) () (6)
Jan 22, 2024	44	APPLICATION of Non-Resident Attorney Renee M. Griffin to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771671) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	42	APPLICATION of Non-Resident Attorney Jennalee N. Beazley to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771606) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	47	APPLICATION of Non-Resident Attorney Andrew V. Trask to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771724) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	41	APPLICATION of Non-Resident Attorney Arthur J. Argall, III to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771536) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	46	APPLICATION of Non-Resident Attorney Ellen E. Oberwetter to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771708) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	43	APPLICATION of Non-Resident Attorney Haylee Bernal Anderson to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771649) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 22, 2024	45	APPLICATION of Non-Resident Attorney Kathryn S. Kayali to Appear Pro Hac Vice on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Pro Hac Vice Fee - $500 Fee Paid, Receipt No. ACACDC-36771690) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/22/2024) (Proposed Order) (1)
Jan 20, 2024	37	APPLICATION to file document Ex Parte Application for Scheduling Order for Preliminary Injunction Proceedings under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Andrew V. Trask, # 2 Unredacted Document, # 3 Redacted Document, # 4 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) () (9)
Jan 20, 2024	38	EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Declaration of Andrew V. Trask, # 3 Exhibit 1 through 8, # 4 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) () (19)
Jan 20, 2024	39	OPPOSITION re: EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) 38 filed by Defendant Amgen, Inc.. (Attorney Shawn Scott Ledingham, Jr added to party Amgen, Inc.(pty:dft))(Ledingham, Shawn) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (5)
Jan 20, 2024	40	CERTIFICATION AND NOTICE of Interested Parties (Ledingham, Shawn) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (1)
Jan 20, 2024	38	EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Declaration of Andrew V. Trask, # 3 Exhibit 1 through 8, # 4 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Exhibit A) (6)
Jan 20, 2024	38	EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Declaration of Andrew V. Trask, # 3 Exhibit 1 through 8, # 4 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Declaration of Andrew V. Trask) (6)
Jan 20, 2024	38	EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Declaration of Andrew V. Trask, # 3 Exhibit 1 through 8, # 4 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Exhibit 1 through 8) (25)
Jan 20, 2024	38	EX PARTE APPLICATION for Order for Setting Schedule for Preliminary Injunction Proceedings (Redacted) filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Declaration of Andrew V. Trask, # 3 Exhibit 1 through 8, # 4 Proposed Order) (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Proposed Order) (4)
Jan 20, 2024	37	APPLICATION to file document Ex Parte Application for Scheduling Order for Preliminary Injunction Proceedings under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Andrew V. Trask, # 2 Unredacted Document, # 3 Redacted Document, # 4 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Declaration of Andrew V. Trask) (5)
Jan 20, 2024	37	APPLICATION to file document Ex Parte Application for Scheduling Order for Preliminary Injunction Proceedings under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Andrew V. Trask, # 2 Unredacted Document, # 3 Redacted Document, # 4 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Redacted Document) (30)
Jan 20, 2024	37	APPLICATION to file document Ex Parte Application for Scheduling Order for Preliminary Injunction Proceedings under seal filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Declaration of Andrew V. Trask, # 2 Unredacted Document, # 3 Redacted Document, # 4 Proposed Order)(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/20/2024) (Proposed Order) (2)
Jan 16, 2024	34	ORDER TO REASSIGN CASE due to self-recusal pursuant to this Court's General Order in the Matter of Assignment of Cases and Duties to the District Judges by Judge John A. Kronstadt. Case transferred from Judge John A. Kronstadt to the calendar of Judge John W. Holcomb for all further proceedings. Case number now reads as 2:24-cv-00264-JWH-Ex. (aco) [Transferred from California Central on 4/17/2024.] (Entered: 01/16/2024) (1)
Jan 16, 2024	35	Notice of Pendency of Other Actions or Proceedings Pursuant to L.R. 83-1.4 filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/16/2024) (18)
Jan 16, 2024	36	PROOF OF SERVICE Executed by Plaintiff Regeneron Pharmaceuticals, Inc., upon Defendant Amgen, Inc. served on 1/12/2024, answer due 2/2/2024. Service of the Summons and Complaint were executed upon Rebecca Vang, Process Specialist for CSC-Lawyers Incorporating Service - Agent for Service of Process in compliance with Federal Rules of Civil Procedure by personal service (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/16/2024) (7)
Jan 12, 2024	7	NOTICE OF ASSIGNMENT to District Judge Sherilyn Peace Garnett and Magistrate Judge Charles F. Eick. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	8	NOTICE TO PARTIES OF COURT-DIRECTED ADR PROGRAM filed. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (2)
Jan 12, 2024	9	Notice to Counsel Re Consent to Proceed Before a United States Magistrate Judge. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	10	21 DAY Summons Issued re Complaint (Attorney Civil Case Opening) 1 as to Defendant Amgen, Inc. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (2)
Jan 12, 2024	11	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Ellen E Oberwetter on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	12	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Andrew V Trask on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	13	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Shau P. Mahaffy on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	14	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Kathryn S. Kayali on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	15	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Arthur J. Argall III on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	16	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Adam Pan on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	17	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Rebecca A. Carter on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	18	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Renee M. Griffin on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	19	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Haylee N Bernal on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	20	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Jennalee Beazley on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	21	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Andrew E. Goldsmith on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	22	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Elizabeth S. Weiswasser on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	23	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Anish R. Desai on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	24	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Natalie C. Kennedy on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	25	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Tom Yu on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	26	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Kathryn Leicht on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	27	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Rocco Recce on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	28	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Zhen Lin on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	29	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Kellie Van Beck on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	30	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Christopher M. Pepe on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	31	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Priyata Y. Patel on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	32	NOTICE OF PRO HAC VICE APPLICATION DUE for Non-Resident Attorney Matthew Sieger on behalf of Plaintiff. A document recently filed in this case lists you as an out-of-state attorney of record. However, the Court has not been able to locate any record that you are admitted to the Bar of this Court, and you have not filed an application to appear Pro Hac Vice in this case. Accordingly, within 5 business days of the date of this notice, you must either (1) have your local counsel file an application to appear Pro Hac Vice (Form G-64) and pay the applicable fee, or (2) complete the next section of this form and return it to the court at cacd_attyadm@cacd.uscourts.gov. You have been removed as counsel of record from the docket in this case, and you will not be added back to the docket until your Pro Hac Vice status has been resolved. (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 12, 2024	N/A	NOTICE TO ATTORNEY ADMISSIONS re: Athony R. Bisconti, Bar No. 269230, David I. Berl, Bar No. 21176, Thomas S. Fletcher, Bar No. 262693 information correction request re Attorney moved to new address,Firm name correction/modification,Firm or Attorney Fax/Telephone Number Change, re Complaint (Attorney Civil Case Opening) 1 . (et) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (0)
Jan 12, 2024	33	NOTICE AND ORDER REGARDING TRANSFER AND/OR REASSIGNMENT OF PATENT CASE by Judge Sherilyn Peace Garnett. Case transferred from Judge Sherilyn Peace Garnett to Judge John A. Kronstadt for all further proceedings. Case number now reads 2:24-cv-00264 JAK(Ex). (rn) [Transferred from California Central on 4/17/2024.] (Entered: 01/12/2024) (1)
Jan 11, 2024	6	Notice Filing of Motion for Transfer of Action to the Northern District of West Virginia Pursuant to 28 U.S.C. 1407 for Coordinated Pretrial Proceedings filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/11/2024) (12)
Jan 10, 2024	1	COMPLAINT Receipt No: ACACDC-36708375 - Fee: $405, filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1 -10, # 2 Exhibits 11 -20, # 3 Exhibits 21 -32) (Attorney Anthony R Bisconti added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) () (30)
Jan 10, 2024	2	Request for Clerk to Issue Summons on Complaint (Attorney Civil Case Opening), 1 filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (2)
Jan 10, 2024	3	CIVIL COVER SHEET filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (3)
Jan 10, 2024	4	NOTICE of Interested Parties filed by Plaintiff Regeneron Pharmaceuticals, Inc., (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (1)
Jan 10, 2024	5	REPORT ON THE FILING OF AN ACTION Regarding a Patent or a Trademark (Initial Notification) filed by Regeneron Pharmaceuticals, Inc.. (Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (2)
Jan 10, 2024	1	COMPLAINT Receipt No: ACACDC-36708375 - Fee: $405, filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1 -10, # 2 Exhibits 11 -20, # 3 Exhibits 21 -32) (Attorney Anthony R Bisconti added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (Exhibits 1 -10) (30)
Jan 10, 2024	1	COMPLAINT Receipt No: ACACDC-36708375 - Fee: $405, filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1 -10, # 2 Exhibits 11 -20, # 3 Exhibits 21 -32) (Attorney Anthony R Bisconti added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (Exhibits 11 -20) (30)
Jan 10, 2024	1	COMPLAINT Receipt No: ACACDC-36708375 - Fee: $405, filed by Plaintiff Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1 -10, # 2 Exhibits 11 -20, # 3 Exhibits 21 -32) (Attorney Anthony R Bisconti added to party Regeneron Pharmaceuticals, Inc.(pty:pla))(Bisconti, Anthony) [Transferred from California Central on 4/17/2024.] (Entered: 01/10/2024) (Exhibits 21 -32) (30)

Lawsuits

Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. > Documents